Latest Health News
Haemophilus Influenzae Type B Outbreak in Alberta, Canada Among Homeless
ProMED reports a Haemophilus influenzae type B case linked to homelessness in Alberta, Canada, as of December 26, 2025. This invasive bacterial infection poses risks to vulnerable populations. Health authorities are monitoring for further spread.
Theileriosis Alert in Kansas Cattle, USA
An alert for theileriosis affecting cattle in Kansas was issued on December 26, 2025, via ProMED. The parasitic disease threatens livestock health and agriculture. Farmers are advised to enhance biosecurity measures.
Nationwide Measles Cases in Australia
Eighteenth measles case reported nationwide in Australia as of December 23, 2025. Ongoing outbreaks underscore vaccination gaps. Public health campaigns urge immunization to curb spread.
Cholera Surge Across Africa Reported by Africa CDC
Africa CDC warns of a significant cholera surge in multiple African countries as of December 23, 2025. Heightened cases strain health systems amid poor sanitation. Emergency responses focus on water treatment and vaccines.
Measles Outbreak in Uruguay's Río Negro Department
Sarampión (measles) outbreak in Río Negro, Uruguay, affects anti-vaccination communities and health workers, reported December 23, 2025. Vaccine hesitancy complicates containment. Local authorities push community education.
Hantavirus Activity Across Americas per PAHO/WHO
PAHO/WHO reports regional hantavirus cases in the Americas, fortieth update on December 23, 2025. Rodent-borne virus causes severe respiratory illness. Prevention emphasizes rodent control and hygiene.
US Signs New Health Deals with 9 African Countries
On December 26, 2025, the US finalized health agreements with 9 African nations, cutting funding by 49% but shifting to government-to-government aid for HIV and malaria. Deals total billions, excluding South Africa due to disputes. Mozambique receives over $1.8 billion.
CDC Ends Universal Hepatitis B Vaccine Recommendation for US Newborns
CDC adopted individual-based decisions for hepatitis B vaccination in newborns of negative-testing mothers, delaying first dose to at least two months. This 2025 policy shift prioritizes risk assessment over universal protocols.
New Nitinol BPH Stents Zenflow and ProVee FDA Approved
In late 2025, FDA approved two nitinol-based stents, Zenflow and ProVee, expanding office-based treatments for benign prostatic hyperplasia. These minimally invasive options promise faster recovery. AI tools may aid future patient selection.
First Personalized CRISPR Therapy Success for Rare Genetic Disease
In February 2025, a baby received the world's first in-body CRISPR gene-editing for a lethal liver disorder, showing milestone progress by November. This breakthrough paves way for treating other genetic conditions. Lifelong monitoring continues.
Polatuzumab Vedotin Improves Survival in Relapsed DLBCL
Phase 3 POLARGO trial showed polatuzumab vedotin with R-GemOx boosted survival in transplant-ineligible relapsed/refractory diffuse large B-cell lymphoma patients. Presented at 2025 European Hematology Association Congress. Offers new option for hard-to-treat cases.
Histotripsy Ultrasound Technique Expands Beyond Liver Cancer
Histotripsy, using high-frequency ultrasound for tumor destruction, advances to kidney, prostate, and pancreas cancers after liver approval. Long-term data pending, but shows promise in solid tumors. Enhances non-invasive oncology options.